REAL-WORLD MULTICENTER COMPARISON OF SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT

Anthony Buisson  ¹     Maria Nachury  ²     Thomas Guilmoteau  ²     Romain Altwegg  ³     Xavier Treton  ⁴     Mathurin Fumery  ⁵     Mélanie Serrero  ⁶     Eloïse Leclerc  ⁶     Ludovic Caillo  ⁷     Bruno Pereira  ⁷     Aurelien Amiot  ⁸     Guillaume Bouguen  ^9    
1 CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
² CHRU Lille, Courbevoie Cedex, France
³ Hopital Saint Eloi, Montpellier Cedex 5, France
⁴ Hopital Beaujon, Asnieres, France
⁵ Amiens University Hospital, Amiens, France
⁶ Hopital Nord, Marseille, France
⁷ CHU de Nimes, Nîmes, France
⁸ Henri Mondor Hospital, APHP, Creteil, France
⁹ CHU Pontchaillou, Rennes, France

Session
Investigator studies in IBD I (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)